Nigeria faces macro risks with rising oil prices and a strong USD. Despite a rate cut, high inflation persists, and oil's benefit to the naira is delayed.
EBC Financial Group notes that avoiding the Suez is lengthening voyages and raising freight and insurance costs, fueling inflation in import-heavy economies.
KOSPI tumbled for a second day, triggering circuit breakers, as the Iran war lifted oil prices and crushed risk appetite. Here is what drove it, and what comes next for Korean stocks.
Moderna agreed to pay $950M to settle a major LNP patent fight. Here is what the deal changes for MRNA stock, what it costs in cash, and what risks remain.
CrowdStrike reports earnings today after the close. Here is what matters most for CRWD stock: revenue and EPS versus guidance, ARR, and net new ARR, and free cash flow.
AVAV stock whipsawed after SCAR contract headlines. Here is what SCAR means, the size of the risk, the latest guidance, and the key AVAV technical levels.
